Anjali Mittal
Overview
Explore the profile of Anjali Mittal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Osama M, Sharma S, Chatterjee P, Mittal A, Andley M, Kakkar A
Indian J Surg Oncol
. 2024 Sep;
15(Suppl 3):374-378.
PMID: 39328726
Primary mucoepidermoid carcinoma of the esophagus is a rare condition characterized by a combination of squamous and mucin-secreting glandular malignant cells. Its clinical recognition is often challenging, pre-operative diagnosis is...
2.
Scott A, Mittal A, Meghdadi B, Palavalasa S, Achreja A, OBrien A, et al.
medRxiv
. 2023 Nov;
PMID: 37961582
Significance: This study is the first to directly measure biosynthetic flux in both glioma and cortical tissue in human brain cancer patients. Brain tumors rewire glucose carbon utilization away from...
3.
Mittal A, Singh M, Singh S, Jain A, Barman K
J Cytol
. 2023 Jan;
39(4):188-189.
PMID: 36605870
No abstract available.
4.
Sharma A, Nair R, Achreja A, Mittal A, Gupta P, Balakrishnan K, et al.
Sci Adv
. 2022 Sep;
8(39):eabq5575.
PMID: 36170375
The connections between metabolic state and therapy resistance in multiple myeloma (MM) are poorly understood. We previously reported that electron transport chain (ETC) suppression promotes sensitivity to the BCL-2 antagonist...
5.
Achreja A, Yu T, Mittal A, Choppara S, Animasahun O, Nenwani M, et al.
Nat Metab
. 2022 Sep;
4(9):1119-1137.
PMID: 36131208
Recurrent loss-of-function deletions cause frequent inactivation of tumour suppressor genes but often also involve the collateral deletion of essential genes in chromosomal proximity, engendering dependence on paralogues that maintain similar...
6.
Mittal A, Nenwani M, Sarangi I, Achreja A, Lawrence T, Nagrath D
Trends Cancer
. 2022 Jun;
8(10):855-869.
PMID: 35750630
Radiation is frequently administered for cancer treatment, but resistance or remission remains common. Cancer cells alter their metabolism after radiotherapy to reduce its cytotoxic effects. The influence of altered cancer...
7.
Sharma A, Mittal A, Puri V, Kumar P, Singh I
3 Biotech
. 2020 Oct;
10(11):464.
PMID: 33088660
The wound healing process is characterized by varied biological and molecular cascades including inflammation, tissue proliferation, and remodeling phase. To augment and maintain these cascades, an all-natural matrix system is...
8.
Zhu Z, Achreja A, Meurs N, Animasahun O, Owen S, Mittal A, et al.
Nat Metab
. 2020 Jul;
2(8):775-792.
PMID: 32694827
Branched-chain amino acids (BCAAs) supply both carbon and nitrogen in pancreatic cancers, and increased levels of BCAAs have been associated with increased risk of pancreatic ductal adenocarcinomas (PDACs). It remains...
9.
Bajpai R, Sharma A, Achreja A, Edgar C, Wei C, Siddiqa A, et al.
Nat Commun
. 2020 Mar;
11(1):1228.
PMID: 32144272
The BCL-2 antagonist venetoclax is highly effective in multiple myeloma (MM) patients exhibiting the 11;14 translocation, the mechanistic basis of which is unknown. In evaluating cellular energetics and metabolism of...
10.
Jaiswal D, Mittal A, Nagrath D, Wangikar P
Methods Mol Biol
. 2020 Jan;
2088:33-50.
PMID: 31893369
Accurate quantification of mass isotopolog distribution (MID) of intracellular metabolites is a key requirement for C metabolic flux analysis (C-MFA). Liquid chromatography coupled with mass spectrometry (LC/MS) has emerged as...